GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » EV-to-EBIT

Syra Health (Syra Health) EV-to-EBIT : -2.41 (As of May. 11, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Syra Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Syra Health's Enterprise Value is $6.94 Mil. Syra Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.88 Mil. Therefore, Syra Health's EV-to-EBIT for today is -2.41.

The historical rank and industry rank for Syra Health's EV-to-EBIT or its related term are showing as below:

SYRA' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.75   Med: -2.75   Max: -1
Current: -2.41

During the past 4 years, the highest EV-to-EBIT of Syra Health was -1.00. The lowest was -7.75. And the median was -2.75.

SYRA's EV-to-EBIT is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.68 vs SYRA: -2.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Syra Health's Enterprise Value for the quarter that ended in Dec. 2023 was $3.49 Mil. Syra Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.88 Mil. Syra Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -82.63%.


Syra Health EV-to-EBIT Historical Data

The historical data trend for Syra Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syra Health EV-to-EBIT Chart

Syra Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - -1.21

Syra Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only - - - -7.91 -1.21

Competitive Comparison of Syra Health's EV-to-EBIT

For the Medical Care Facilities subindustry, Syra Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syra Health's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Syra Health's EV-to-EBIT falls into.



Syra Health EV-to-EBIT Calculation

Syra Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6.938/-2.884
=-2.41

Syra Health's current Enterprise Value is $6.94 Mil.
Syra Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syra Health  (NAS:SYRA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Syra Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-2.884/3.490449591
=-82.63 %

Syra Health's Enterprise Value for the quarter that ended in Dec. 2023 was $3.49 Mil.
Syra Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syra Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Syra Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Syra Health (Syra Health) Business Description

Traded in Other Exchanges
N/A
Address
1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.
Executives
Sandeep Allam director, officer: President and Chair 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed 10 percent owner 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi director, officer: Chief Executive Officer 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas 10 percent owner 2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc 10 percent owner 6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad officer: CFO and COO 1119 KEYSTONE WAY N., #201, CARMEL IN 46032